Additional European Equity News

AstraZeneca (AZN LN) - Lynparza plus abiraterone approved in Japan for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. (AstraZeneca) 

BAE Systems (BA/ LN) - BAE was awarded a USD 113.1mln US Army contract modification for M2A4 and M7A4 Bradley Fighting Vehicles. (Newswires)

CTS Eventim (EVD GY) - H1 (EUR): Revenue 1.01bln, first time over 1bln generated in a HY period. Expects revenue and normalised EBITDA to be higher for 2023 YY. (Newswires)

Engie (ENGI FP) - Acquisition of Broad Reach Power in US. Step towards objective of reaching 10GW battery capacity within the group by 2030. Completion of transaction is expected by Q4'23, subject to the fulfilment of certain anti-trust and regulatory approvals. (Newswires)

Drax (DRX LN) - Appointment of Chair Designate Bertone, effective 24 August, to replace Philip Cox. (Newswires)

Hays (HAS LN) - Prelim FY23 (GBP): 192mln (prev. 204mln YY), Net Fees 1.29bln (prev. 1.19bln YY). (Newswires)

Harbour Energy (HBR LN) - H1 (USD): Pretax Profit 0.4bln (prev. 1.5bln YY), FCF 1bln (prev. 1.4bln YY), EBITDA 1.4bln (prev. 2.0bln YY). FY 23 Total Capex 1bln (prev. 1.1bln). (Newswires)

Norwegian Air (NAS NO) - CEO believes Boeing (BA) is moving to a situation where delays in deliveries are shorter. (Newswires)

Volkswagen (VOW3 GY) - Begun purchasing strategically important chips which it believes will be in short supply in the future. Currently, no supply deal with TSMC (2330 TW) but the Cos meet every few weeks. (Newswires)

Symrise (SY1 GY) upgraded to Overweight from Underweight at Morgan Stanley

24 Aug 2023 - 07:20- EquitiesEconomic Commentary- Source: Newsquawk